Emergent Biosolutions
EBS
EBS
168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.
Holders
168
Holders Change
+36
Holders Change %
+27.27%
% of All Funds
4.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
50
Closed
8
Calls
$319K
Puts
–
Net Calls
+$319K
Net Calls Change
-$278K
Top Buyers
1 |
BC
1
Broadfin Capital
New York
|
$45.6M |
2 |
NI
2
Numeric Investors
Boston,
Massachusetts
|
$15.6M |
3 |
3
State Street
Boston,
Massachusetts
|
$31.7M |
4 |
GT
4
Glenmede Trust
Philadelphia,
Pennsylvania
|
$10.5M |
5 |
GAM
5
Gotham Asset Management
New York
|
$6.54M |